MENU

HALO Halozyme Therapeutics Chart, History Price & Graph

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry: #Biotechnology
HALO
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HALO showed earnings on February 17, 2026. You can read more about the earnings report here.
View a ticker or compare two or three
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HALO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
-1.96%
AXON - HALO
47%
Loosely correlated
-2.34%
XENE - HALO
41%
Loosely correlated
-2.59%
SGMO - HALO
35%
Loosely correlated
-1.09%
VCYT - HALO
34%
Loosely correlated
-0.98%
TECH - HALO
32%
Poorly correlated
+1.51%
More
Halozyme Therapeutics (HALO) Stocks Price History Chart, Support & Resistance Graph - Tickeron.com